Document is current
Any future updates will be listed below
-
Authors
Abdou, Kareem http://orcid.org/0000-0002-1033-1650
Nomoto, Masanori http://orcid.org/0000-0003-0301-6924
Aly, Mohamed H. http://orcid.org/0000-0002-4617-4909
Ibrahim, Ahmed Z. http://orcid.org/0009-0002-5281-9950
Choko, Kiriko
Okubo-Suzuki, Reiko
Muramatsu, Shin-ichi http://orcid.org/0000-0002-3185-7790
Inokuchi, Kaoru http://orcid.org/0000-0002-5393-3133
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP18H05213, JP23H05476, JP19K16892, 20H03554, 23H02785)
MEXT | JST | Core Research for Evolutional Science and Technology (JPMJCR13W1, JPMJCR23N2)
Ministry of Education, Culture, Sports, Science and Technology (JP25115002)
Takeda Science Foundation
Japan Agency for Medical Research and Development (JP23gm6510028)
- License Information
-
More Information
Article History
Received: 19 August 2023
Accepted: 14 May 2024
First Online: 24 June 2024
Competing interests
: S.M. owns equity in a company, Gene Therapy Research Institution, that commercializes the use of AAV vectors for gene therapy applications. To the extent that the work in this manuscript increases the value of these commercial holdings, S.M. has a conflict of interest. The other authors declare no competing interests.
